Edible nanoparticles made from ginger reduced pro-inflammatory cytokines, increased anti-inflammatory cytokines, reduced acute colitis, enhanced intestinal repair and prevented chronic colitis and colitis-associated cancer in mouse models of Crohn's disease and ulcerative colitis, which together make up inflammatory bowel disease (IBD).